型号：GM-J000291-unknow

应用：肿瘤类型Kidney carcinoma，诱导方法，发病概率95 - 100，参考文献1 Reference: Kobayashi T, Cancer Res (1999)

型号：GM-J000289-unknow

应用：肿瘤类型Kidney - Cortex tumor，诱导方法，发病概率100，参考文献1 Reference: Onda H, J Clin Invest (1999)

型号：GM-J000288-unknow

应用：肿瘤类型Kidney - Cortex adenoma，诱导方法streptozotocin，发病概率69 - 93，参考文献1 Reference: Hard GC, Cancer Res (1985)

型号：GM-J000287-unknow

应用：肿瘤类型Kidney - Cortex adenoma，诱导方法，发病概率100，参考文献1 Reference: Onda H, J Clin Invest (1999)

型号：GM-J000286-unknow

应用：肿瘤类型Intestine tumor - polypoid，诱导方法piroxicam, AIN-93M，发病概率85，参考文献1 Reference: Zhang W, Mol Carcinog (2013)

型号：GM-J000285-unknow

应用：肿瘤类型Intestine tumor - mucinous，诱导方法，发病概率92，参考文献1 Reference: Tosti E, Cell Mol Gastroenterol Hepatol (2022)

型号：GM-J000284-unknow

应用：肿瘤类型Intestine tumor，诱导方法N-methyl-N-nitrosourea (MNU)，发病概率5.6 - 82，参考文献1 Reference: Qin X, Carcinogenesis (2000)

型号：GM-J000283-unknow

应用：肿瘤类型Intestine tumor，诱导方法，发病概率83，参考文献1 Reference: Trinh BN, Mol Cell Biol (2002)

型号：GM-J000282-unknow

应用：肿瘤类型Intestine tumor，诱导方法4-hydroxytamoxifen (4-OHT) (for inducing expression from mutant alleles)，发病概率85.07，参考文献1 Reference: Boutin AT, Genes Dev (2017)

型号：GM-J000281-unknow

应用：肿瘤类型Intestine tumor，诱导方法，发病概率89，参考文献1 Reference: Tosti E, Cell Mol Gastroenterol Hepatol (2022)